Inactive Instrument

News Monterey Innovation Acquisition Corp.

Equities

MTRY

US61240F1084

Summary

Unlock all the news: Be the first to know and act before the market!

Monterey Innovation Acquisition Corp.(NasdaqGM:MTRY) dropped from NASDAQ Composite Index	Nov. 20	CI
Monterey Innovation Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Monterey Innovation Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-18	CI
Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
MONTEREY INNOVATION ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-17	AQ
Monterey Innovation Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-04-16	CI
Monterey Bio Acquisition to Change Name to Monterey Innovation Acquisition	23-03-10	MT
MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-10	AQ
Monterey Bio Acquisition Corporation Announces Board Changes	23-03-10	CI
Monterey Bio Acquisition Corporation Appoints Murat Omur as Chief Executive Officer	23-03-10	CI
Monterey Bio Acquisition Corporation Appoints Sean McGann as Chief Financial Officer	23-03-10	CI
MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-10	AQ
Monterey Bio Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-10-11	AQ
Monterey Innovation Acquisition Corp. announced that it expects to receive $0.7 million in funding from Northstar Bio Ventures, LLC, Chardan Monterey Investments LLC	22-10-06	CI
MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	22-09-30	AQ
MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-11	AQ
Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-13	AQ
Monterey Bio Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Monterey Innovation Acquisition Corp.

Equities

MTRY

US61240F1084

Summary

Filters